Close Menu

New Journal in Town

A new scientific journal backed by venture capitalist Tim O'Reilly relies on a one-time fee for researchers to be able to publish articles there, reports Reuters. The journal, called PeerJ, is the brainchild of Peter Binfield — formerly of PLoS One — and Jason Hoyt — formerly at Mendeley — and it will focus on the biological and medical sciences.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.